Aug 4, 2008 - Two New Drugs Help Against Pleural Mesothelioma
Navelbine, an anti-cancer chemotherapy drug, has common side effects that include low blood counts, muscle weakness and vomiting. Platinol's side effects are very similar, although many patients do not experience them. Both drugs are administered intravenously.
Mesothelioma attorneys have found that pleural mesothelioma, a fatal type of cancer, affects the pleural lining of the lines and is caused by exposure to even small amounts of asbestos, a known carcinogen. Patients diagnosed with mesothelioma generally succumb to this aggressive disease in less than two years. According to mesothelioma lawyers and physicians, there is no known cure for mesothelioma at this time. Survival rate is less than one percent and early detection and treatment are important.
A total of 54 patients participated in the study, with all receiving four rounds of navelbine and platinol treatment. The median survival rate associated with the study was 16.8 months, with three-year survival rates around four percent.
Details were included in a publication released June 10 by the British Journal.